Verve Therapeutics
VERV
#6795
Rank
S$0.65 B
Marketcap
$7.79
Share price
11.24%
Change (1 day)
-58.87%
Change (1 year)

EPS for Verve Therapeutics (VERV)

EPS in 2023 (TTM): -$4.32

According to Verve Therapeutics's latest financial reports the company's current EPS (TTM) is -$4.30. In 2022 the company made an earnings per share (EPS) of -$3.96 a decrease over its 2021 EPS that were of -$3.43.

EPS history for Verve Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.329.15%
2022-$3.9615.54%
2021-$3.4361.32%
2020-$2.13